Lindquist, L. & Vapalahti, O. Tick-borne encephalitis. Lancet 371, 1861–1871 (2008).
Süss, J. Tick-borne encephalitis 2010: epidemiology, risk areas, and virus strains in Europe and Asia-an overview. Ticks Tick Borne Dis. 2, 2–15 (2011).
Van Heuverswyn, J. et al. Spatiotemporal spread of tick-borne encephalitis in the EU/EEA, 2012 to 2020. Euro Surveill. 28, 2200543 (2023).
Albinsson, B. et al. Seroprevalence of tick-borne encephalitis virus and vaccination coverage of tick-borne encephalitis, Sweden, 2018 to 2019. Euro Surveill. 29, 2300221 (2024).
Heinz, F. X. et al. Vaccination and tick-borne encephalitis, central Europe. Emerg. Infect. Dis. 19, 69–76 (2013).
Erber, W. & Schmitt, H.-J. Self-reported tick-borne encephalitis (TBE) vaccination coverage in Europe: results from a cross-sectional study. Ticks Tick Borne Dis. 9, 768–777 (2018).
Kubinski, M. et al. Tick-borne encephalitis virus: a quest for better vaccines against a virus on the rise. Vaccines 8, 451 (2020).
Ruzek, D. et al. Tick-borne encephalitis in Europe and Russia: review of pathogenesis, clinical features, therapy, and vaccines. Antiviral Res. 164, 23–51 (2019).
Hasan, S. S., Sevvana, M., Kuhn, R. J. & Rossmann, M. G. Structural biology of Zika virus and other flaviviruses. Nat. Struct. Mol. Biol. 25, 13–20 (2018).
Pierson, T. C. & Diamond, M. S. The continued threat of emerging flaviviruses. Nat. Microbiol. 5, 796–812 (2020).
Kanojia, A., Sharma, M., Shiraz, R. & Tripathi, S. Flavivirus-host interaction landscape visualized through genome-wide CRISPR screens. Viruses 14, 2164 (2022).
See, W. R., Yousefi, M. & Ooi, Y. S. A review of virus host factor discovery using CRISPR screening. mBio 15, e0320523 (2024).
Yousefi, M. et al. GeneRaMeN enables integration, comparison, and meta-analysis of multiple ranked gene lists to identify consensus, unique, and correlated genes. Brief. Bioinform. 25, bbae452 (2024).
Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783–784 (2014).
Han, J. et al. Genome-wide CRISPR/Cas9 screen identifies host factors essential for influenza virus replication. Cell Rep. 23, 596–607 (2018).
Kim, D. H. et al. Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain. J. Biol. Chem. 271, 8373–8380 (1996).
Clark, L. E. et al. VLDLR and ApoER2 are receptors for multiple alphaviruses. Nature 602, 475–480 (2022).
Li, W. et al. Shifts in receptors during submergence of an encephalitic arbovirus. Nature 632, 614–621 (2024).
Rosendal, E. et al. Influence of the pre-membrane and envelope proteins on structure, pathogenicity, and tropism of tick-borne encephalitis virus. J. Virol. https://doi.org/10.1128/jvi.00870-25 (2025).
Rey, F. A., Stiasny, K. & Heinz, F. X. Flavivirus structural heterogeneity: implications for cell entry. Curr. Opin. Virol. 24, 132–139 (2017).
Anwar, M. N. et al. The interactions of flaviviruses with cellular receptors: implications for virus entry. Virology 568, 77–85 (2022).
Palakurty, S. et al. The VLDLR entry receptor is required for the pathogenesis of multiple encephalitic alphaviruses. Cell Rep. 43, 114809 (2024).
Monteil, V. M. et al. Crimean-Congo haemorrhagic fever virus uses LDLR to bind and enter host cells. Nat. Microbiol. 9, 1499–1512 (2024).
Finkelshtein, D., Werman, A., Novick, D., Barak, S. & Rubinstein, M. LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus. Proc. Natl Acad. Sci. USA 110, 7306–7311 (2013).
Xu, Z.-S. et al. LDLR is an entry receptor for Crimean-Congo hemorrhagic fever virus. Cell Res. 34, 140–150 (2024).
Ganaie, S. S. et al. Lrp1 is a host entry factor for Rift Valley fever virus. Cell 184, 5163–5178.e24 (2021).
Schwarz, M. M. et al. Oropouche orthobunyavirus infection is mediated by the cellular host factor Lrp1. Proc. Natl Acad. Sci. USA 119, e2204706119 (2022).
Cosset, F.-L. & Denolly, S. Lipoprotein receptors: a little grease for enveloped viruses to open the lock? J. Biol. Chem. 300, 107849 (2024).
Zimmerman, O., Holmes, A. C., Kafai, N. M., Adams, L. J. & Diamond, M. S. Entry receptors—the gateway to alphavirus infection. J. Clin. Invest. 133, e165307 (2023).
Nikolic, J. et al. Structural basis for the recognition of LDL-receptor family members by VSV glycoprotein. Nat. Commun. 9, 1029 (2018).
Jangra, R. K. et al. Protocadherin-1 is essential for cell entry by New World hantaviruses. Nature 563, 559–563 (2018).
Cao, D., Ma, B., Cao, Z., Zhang, X. & Xiang, Y. Structure of Semliki Forest virus in complex with its receptor VLDLR. Cell 186, 2208–2218.e15 (2023).
Adams, L. J. et al. Structural and functional basis of VLDLR usage by eastern equine encephalitis virus. Cell 187, 360–374 (2024).
Fan, X. et al. Molecular basis for shifted receptor recognition by an encephalitic arbovirus. Cell 188, 2957–2973.e28 (2025).
Song, H. et al. Molecular basis of arthritogenic alphavirus receptor MXRA8 binding to chikungunya virus envelope protein. Cell 177, 1714–1724.e12 (2019).
Basore, K. et al. Cryo-EM structure of chikungunya virus in complex with the Mxra8 receptor. Cell 177, 1725–1737 (2019).
Sevvana, M. & Kuhn, R. J. Mapping the diverse structural landscape of the flavivirus antibody repertoire. Curr. Opin. Virol. 45, 51–64 (2020).
Mandl, C. W., Allison, S. L., Holzmann, H., Meixner, T. & Heinz, F. X. Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site. J. Virol. 74, 9601–9609 (2000).
Vaney, M.-C. et al. Evolution and activation mechanism of the flavivirus class II membrane-fusion machinery. Nat. Commun. 13, 3718 (2022).
Malashkevich, V. N., Kammerer, R. A., Efimov, V. P., Schulthess, T. & Engel, J. The crystal structure of a five-stranded coiled coil in COMP: a prototype ion channel? Science 274, 761–765 (1996).
Jerabek-Willemsen, M., Wienken, C. J., Braun, D., Baaske, P. & Duhr, S. Molecular interaction studies using microscale thermophoresis. Assay Drug Dev. Technol. 9, 342–353 (2011).
Fan, Q. W., Iosbe, I., Asou, H., Yanagisawa, K. & Michikawa, M. Expression and regulation of apolipoprotein E receptors in the cells of the central nervous system in culture: a review. J. Am. Aging Assoc. 24, 1–10 (2001).
Bílý, T. et al. Electron tomography analysis of tick-borne encephalitis virus infection in human neurons. Sci. Rep. 5, 10745 (2015).
Velay, A. et al. Tick-borne encephalitis virus: molecular determinants of neuropathogenesis of an emerging pathogen. Crit. Rev. Microbiol. 45, 472–493 (2019).
Fares, M. et al. Pathological modeling of TBEV infection reveals differential innate immune responses in human neurons and astrocytes that correlate with their susceptibility to infection. J. Neuroinflamm. 17, 76 (2020).
Salát, J. et al. Development and testing of a new tick-borne encephalitis virus vaccine candidate for veterinary use. Vaccine 36, 7257–7261 (2018).
Zhang, X. et al. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a functional entry factor for tick-borne encephalitis virus. mBio 13, e0286021 (2022).
He, L. et al. Single-cell RNA sequencing of mouse brain and lung vascular and vessel-associated cell types. Sci. Data 5, 180160 (2018).
Daneman, R. et al. The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells. PLoS ONE 5, e13741 (2010).
Moreno, H., Möller, R., Fedeli, C., Gerold, G. & Kunz, S. Comparison of the innate immune responses to pathogenic and nonpathogenic clade B new world arenaviruses. J. Virol. 93, e00148–19 (2019).
Calvo-Garrido, J. et al. Protocol for the derivation, culturing, and differentiation of human iPS-cell-derived neuroepithelial stem cells to study neural differentiation in vitro. STAR Protoc. 2, 100528 (2021).
Stirling, D. R. et al. CellProfiler 4: improvements in speed, utility and usability. BMC Bioinform. 22, 433 (2021).
Spuul, P., Balistreri, G., Kääriäinen, L. & Ahola, T. Phosphatidylinositol 3-kinase-, actin-, and microtubule-dependent transport of Semliki Forest Virus replication complexes from the plasma membrane to modified lysosomes. J. Virol. 84, 7543–7557 (2010).
Thomas, J. M., Klimstra, W. B., Ryman, K. D. & Heidner, H. W. Sindbis virus vectors designed to express a foreign protein as a cleavable component of the viral structural polyprotein. J. Virol. 77, 5598–5606 (2003).
Brown, R. S., Anastasakis, D. G., Hafner, M. & Kielian, M. Multiple capsid protein binding sites mediate selective packaging of the alphavirus genomic RNA. Nat. Commun. 11, 4693 (2020).
Liljeström, P., Lusa, S., Huylebroeck, D. & Garoff, H. In vitro mutagenesis of a full-length cDNA clone of Semliki forest virus: the small 6,000-molecular-weight membrane protein modulates virus release. J. Virol. 65, 4107–4113 (1991).
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens. Genome Biol. 15, 554 (2014).
Vratskikh, O. et al. Dissection of antibody specificities induced by yellow fever vaccination. PLoS Pathog. 9, e1003458 (2013).
Stiasny, K., Brandler, S., Kössl, C. & Heinz, F. X. Probing the flavivirus membrane fusion mechanism by using monoclonal antibodies. J. Virol. 81, 11526–11531 (2007).
Shao, W., Sharma, R., Clausen, M. H. & Scheller, H. V. Microscale thermophoresis as a powerful tool for screening glycosyltransferases involved in cell wall biosynthesis. Plant Methods 16, 99 (2020).
Source link
